Effects of mechanical stress and carvedilol in lamin A/C-deficient dilated cardiomyopathy

Circ Res. 2010 Feb 19;106(3):573-82. doi: 10.1161/CIRCRESAHA.109.204388. Epub 2009 Dec 17.

Abstract

Rationale: Mutations in the LMNA gene, which encodes the nuclear lamina proteins lamin A and lamin C, are the most common cause of familial dilated cardiomyopathy (DCM). Mechanical stress-induced apoptosis has been proposed as the mechanism underpinning DCM in lamin A/C-deficient hearts, but supporting in vivo evidence has been lacking.

Objective: Our aim was to study interventions to modify mechanical stress in heterozygous Lmna knockout (Lmna(+/-)) mice.

Methods and results: Cardiac structure and function were evaluated before and after exercise training, thoracic aortic constriction, and carvedilol treatment. Lmna(+/-) mice develop adult-onset DCM with relatively more severe disease in males. Lmna(+/-) cardiomyocytes show altered nuclear morphology and perinuclear desmin organization, with enhanced responses to hypo-osmotic stress indicative of cytoskeletal instability. Despite these structural defects that provide a template for mechanical stress-induced damage, young Lmna(+/-) mice subjected to 6 weeks of moderate or strenuous exercise training did not show induction of apoptosis or accelerated DCM. In contrast, regular moderate exercise attenuated DCM development in male Lmna(+/-) mice. Sustained pressure overload generated by thoracic aortic constriction depressed ventricular contraction in young wild-type and Lmna(+/-) mice with no sex or genotype differences in the time-course or severity of response. Treatment of male Lmna(+/-) mice from 12 to 40 weeks with the beta-blocker, carvedilol, prevented the dilatation and contractile dysfunction that was observed in placebo-treated mice.

Conclusions: These data suggest that factors other than mechanical stress-induced apoptosis contribute to DCM and provide the first demonstration that regular moderate exercise and carvedilol can modify disease progression in lamin A/C-deficient hearts.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Animals
  • Aorta, Thoracic
  • Apoptosis
  • Carbazoles / therapeutic use*
  • Cardiomyopathy, Dilated / drug therapy
  • Cardiomyopathy, Dilated / genetics*
  • Cardiomyopathy, Dilated / pathology
  • Cardiomyopathy, Dilated / physiopathology
  • Carvedilol
  • Constriction
  • Desmin / analysis
  • Female
  • Genotype
  • Heart / physiopathology*
  • Lamin Type A / deficiency*
  • Lamin Type A / genetics
  • Male
  • Mice
  • Mice, Knockout
  • Myocardium / pathology*
  • Osmotic Pressure
  • Physical Conditioning, Animal
  • Propanolamines / therapeutic use*
  • Stress, Mechanical*
  • Ventricular Dysfunction, Left / pathology
  • Ventricular Dysfunction, Left / physiopathology

Substances

  • Adrenergic beta-Antagonists
  • Carbazoles
  • Desmin
  • Lamin Type A
  • Propanolamines
  • lamin C
  • Carvedilol